Integrated DNA Technologies and Glycon Partner in Australia
News Apr 23, 2010
IDT is among the world’s most respected manufacturers of custom synthetic oligonucleotides and genes. Glycon will offer Australia’s scientists local sales and technical support of IDT’s products, complementing IDT’s existing global customer care network available by phone, email and web chat.
Glycon brings more than a decade’s experience in Australia’s biotechnology sector, with advanced expertise in both oligonucleotides and genetic research. Australian scientists will be able to work directly with Glycon to take the maximum advantage of IDT’s entire product portfolio of synthetic DNA and RNA oligos, genes, and supporting products.
Wendy Scott, Executive Sales Manager of Gylcon explains the benefits of this relationship, “Our experience and knowledge of IDT’s products enables us to provide exceptional customer service and technical expertise. With our background in biomedical science, broad product knowledge base and customer service experience, we can find the most effective solution for all research needs.”
Breakthrough Leads to New Research Into Cancer Treatment for ChildrenNews
The new form of treatment is based on the protein molecule named CD40, which destroys cancerous tumours without harming healthy cell tissue.READ MORE
Gene Associated with Schizophrenia Risk May Regulate NeurodevelopmentNews
The gene is involved in the translation of proteins from RNA and in the proliferation and migration of neurons in the brain.READ MORE
Regenerating Tissues with Gene-targeting MoleculesNews
Stem cells can be triggered to change into heart muscle cells by a new method involving synthetic molecules.READ MORE